Dear Editor, Dupuytren's disease is a benign disorder of autosomal dominant inheritance and variable penetrance involving the gene related to collagen synthesis. It is characterized by fibroproliferation that mainly affects palmar and digital aponeurosis, causing contractures and progressive flexion deformities. [1] [2] [3] The nodules result from the proliferation of myofibroblasts and accumulation of type III collagen in healthy bands and ligaments composed mainly of type I collagen. Free radicals and ischemia may trigger the disease.
It appears to result from a defect in the repair of damaged tissue, an abnormal healing response, an impaired immune response, or a combination of these factors.
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The incidence ranges from 1% to 3%, being more common in Northern Europe and more frequent in men than women (6:1).
Incidence increases with age, with onset in the fifth decade. FIgure 1: Presence of skin retraction on the left fourth finger
The most common location is the palmar region near the fourth, fifth, third and second digits, in this order, in the metacarpophalangeal and proximal interphalangeal joints.
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The clinical picture is characterized by depressions in the palm, with pigment alteration and fibrosis followed by the onset of generally asymptomatic nodules, corresponding to stage A. In 50% of the patients, stage A is followed by the formation of cords that cause a progressive retraction, i.e., stage B. Finally, permanent contracture of the fingers, or stage C, can occur. In this clinical case, the patient was a 55-year-old female, ex-smoker, with a personal history of discoid lupus erythematosus and diabetes mellitus. She had had an asymptomatic nodule in the left palmar region for 4 months. At the examination, the patient presented a 0.3-cm nodule in the metacarpophalangeal region of the fourth finger, covered by healthy, normochromic and distally retracted skin (Figures 1 and 2 ). Hueston test was positive. There was no change in function. Based on the hypothesis of Dupuytren's disease, we referred the patient to the orthopedic service.
The treatment of Dupuytren's disease can be divided into non-surgical and surgical. Non-surgical treatment entails clinical observation with annual control in mild, non-progressive and non-limiting cases. An additional possibility is a collagenase injection directly into the pre-tendinous cord, with studies showing complete resolution of the contracture in 57% to 65% of cases and recurrence within the first year in 10% to 50%, being progressive over the years. 1,3 In early diagnoses, another possible treatment is the injection of triamcinolone; however, a 50% recurrence rate has been reported in the literature. 
